SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-02-000941
Filing Date
2002-03-15
Accepted
2002-03-15 00:00:00
Documents
11
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K NOVAVAX, INC. w57440e10-k.htm 10-K 521499
3 EMPLOYMENT AGREEMENT- JAMES R. MIRTO w57440ex10-7.htm EX-10.7 23661
4 EMPLOYMENT AGREEMENT-DENNIS GENGE w57440ex10-8.htm EX-10.8 23654
5 AGREEMENT OF LEASE-W.M.RICKMAN CONSTRUCTION CO. w57440ex10-10.htm EX-10.10 71821
6 LEASE AGREEMENT- GPG ENTERPRISES w57440ex10-11.htm EX-10.11 63183
7 LEASE AGREEMENT w57440ex10-12.htm EX-10.12 105355
8 FACILITY RESERVATION AGREEMENT w57440ex10-13.htm EX-10.13 77139
9 LIST OF SUBSIDIARIES w57440ex21.htm EX-21 374
10 CONSENT OF ERNST & YOUNG w57440ex23-1.htm EX-23.1 2990
11 CONSENT OF PRICEWATERHOUSECOOPERS w57440ex23-2.htm EX-23.2 820
12 GRAPHIC w57440w5744001.gif GRAPHIC 9979
  Complete submission text file 0000950133-02-000941.txt   903315
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26770 | Film No.: 02576305
SIC: 2836 Biological Products, (No Diagnostic Substances)